Cobicistat: a Novel Pharmacoenhancer for Co-Formulation with HIV Protease and Integrase Inhibitors
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2193-6382
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Cobicistat: a Novel Pharmacoenhancer for Co-Formulation with HIV Protease and Integrase Inhibitors ; volume:2 ; number:2 ; day:3 ; month:9 ; year:2013 ; pages:111-122 ; date:12.2013
Infectious diseases and therapy ; 2, Heft 2 (3.9.2013), 111-122, 12.2013
- Urheber
-
Nathan, Bavithra
Bayley, Jake
Waters, Laura
Post, Frank A.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s40121-013-0013-7
- URN
-
urn:nbn:de:101:1-2019101703164862928539
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:21 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Nathan, Bavithra
- Bayley, Jake
- Waters, Laura
- Post, Frank A.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Integrase inhibitors
Synthesis of an Atropisomeric HIV Integrase Inhibitor
Synthesis of an Atropisomeric HIV Integrase Inhibitor
Synthesis of HIV Integrase Inhibitor MK-1376
Update on Adverse Effects of HIV Integrase Inhibitors
HIV drug resistance against strand transfer integrase inhibitors
Synthesis of an HIV-1 Integrase Allosteric Site Inhibitor
Multiple choices for HIV therapy with integrase strand transfer inhibitors
7‐Step Flow Synthesis of the HIV Integrase Inhibitor Dolutegravir
Integrase and integration: biochemical activities of HIV-1 integrase
Cross-clade simultaneous HIV drug resistance genotyping for reverse transcriptase, protease, and integrase inhibitor mutations by Illumina MiSeq
Investigation of anti-HIV activity, cytotoxicity and HIV integrase inhibitory activity of polyherbal formulation BH extracts
Integrase inhibitors
Synthesis of an Atropisomeric HIV Integrase Inhibitor
Synthesis of an Atropisomeric HIV Integrase Inhibitor
Synthesis of HIV Integrase Inhibitor MK-1376
Update on Adverse Effects of HIV Integrase Inhibitors
HIV drug resistance against strand transfer integrase inhibitors
Synthesis of an HIV-1 Integrase Allosteric Site Inhibitor
Multiple choices for HIV therapy with integrase strand transfer inhibitors
7‐Step Flow Synthesis of the HIV Integrase Inhibitor Dolutegravir
Integrase and integration: biochemical activities of HIV-1 integrase
Cross-clade simultaneous HIV drug resistance genotyping for reverse transcriptase, protease, and integrase inhibitor mutations by Illumina MiSeq
Investigation of anti-HIV activity, cytotoxicity and HIV integrase inhibitory activity of polyherbal formulation BH extracts
Integrase inhibitors
Synthesis of an Atropisomeric HIV Integrase Inhibitor
Synthesis of an Atropisomeric HIV Integrase Inhibitor
Synthesis of HIV Integrase Inhibitor MK-1376
Update on Adverse Effects of HIV Integrase Inhibitors
HIV drug resistance against strand transfer integrase inhibitors
Synthesis of an HIV-1 Integrase Allosteric Site Inhibitor
Multiple choices for HIV therapy with integrase strand transfer inhibitors
7‐Step Flow Synthesis of the HIV Integrase Inhibitor Dolutegravir
Integrase and integration: biochemical activities of HIV-1 integrase
Cross-clade simultaneous HIV drug resistance genotyping for reverse transcriptase, protease, and integrase inhibitor mutations by Illumina MiSeq